iLex Medical Ltd.
Tel Aviv Stock ExchangeTotal Valuation
iLex Medical Ltd. carries a market capitalization of 548.44M, placing it among publicly traded companies globally. Its enterprise value stands at 68.39B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 548.44M |
| Enterprise Value | 68.39B |
Share Statistics
iLex Medical Ltd. currently has 11.19M shares outstanding.
| Shares Outstanding | 11.19M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
iLex Medical Ltd. trades at a trailing price-to-earnings ratio of 1,334.84. The price-to-sales ratio is 75.66, and the price-to-book ratio stands at 113.14.
| PE Ratio | 1,334.84 |
| PS Ratio | 75.66 |
| PB Ratio | 113.14 |
| P/TBV Ratio | 105.66 |
| P/FCF Ratio | 619.18 |
| P/OCF Ratio | 820.53 |
Enterprise Valuation
On an enterprise value basis, iLex Medical Ltd. trades at an EV/EBITDA multiple of 1,372.71 and an EV/FCF ratio of 605.68. The EV/Sales ratio of 75.48 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 1,372.71 provides insight into valuation relative to core operating earnings.
| EV / Sales | 75.48 |
| EV / EBITDA | 1,372.71 |
| EV / EBIT | 1,372.71 |
| EV / FCF | 605.68 |
Financial Position
iLex Medical Ltd. maintains a current ratio of 2.92, meaning it holds 2.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 7.38, indicating elevated leverage, while an interest coverage ratio of 16.85 demonstrates strong ability to service its debt obligations.
| Current Ratio | 2.92 |
| Quick Ratio | 0.96 |
| Debt / Equity | 7.38 |
| Debt / EBITDA | 0.99 |
| Interest Coverage | 16.85 |
Financial Efficiency
iLex Medical Ltd. posts a return on equity of 8.69 and a return on invested capital of 5.19.
| Return on Equity (ROE) | 8.69 |
| Return on Assets (ROA) | 5.25 |
| Return on Invested Capital (ROIC) | 5.19 |
| Return on Capital Employed (ROCE) | 8.36 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 4.14 |
Taxes
Over the trailing twelve months, iLex Medical Ltd. has paid 17.87M in income taxes, reflecting an effective tax rate of 25.81.
| Income Tax | 17.87M |
| Effective Tax Rate | 25.81 |
Stock Price Statistics
iLex Medical Ltd.'s stock has declined approximately -24.18806% over the past 52 weeks. The 50-day moving average sits at 5,017.68, while the 200-day moving average is 5,998.15.
| Beta (5Y) | N/A |
| 52-Week Price Change | -24.18806% |
| 50-Day Moving Average | 5,017.68 |
| 200-Day Moving Average | 5,998.15 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, iLex Medical Ltd. generated 906.15M in revenue and converted that into 51.36M in net income, yielding earnings per share of 4.59. EBITDA reached 49.82M, while operating income came in at 49.82M.
| Revenue | 906.15M |
| Gross Profit | 205.61M |
| Operating Income | 49.82M |
| Pretax Income | 69.23M |
| Net Income | 51.36M |
| EBITDA | 49.82M |
| EBIT | 49.82M |
| Earnings Per Share (EPS) | 4.59 |
Balance Sheet
iLex Medical Ltd. holds 215.30M in cash and equivalents against 49.20M in total debt, resulting in a net debt position of -184.50M. Total book value stands at 605.97M, with working capital of 428.35M providing operational flexibility.
| Cash & Cash Equivalents | 215.30M |
| Total Debt | 49.20M |
| Net Debt | -184.50M |
| Equity (Book Value) | 605.97M |
| Book Value Per Share | 54.11 |
| Working Capital | 428.35M |
Cash Flow
iLex Medical Ltd. produced 83.56M in operating cash flow over the past twelve months. After subtracting -27.17M in capital expenditures, free cash flow totaled 56.39M - equivalent to 5.03 per share.
| Operating Cash Flow | 83.56M |
| Capital Expenditures | -27.17M |
| Free Cash Flow | 56.39M |
| FCF Per Share | 5.03 |
Margins
iLex Medical Ltd. operates with a gross margin of 22.69, reflecting its pricing power and cost economics. The operating margin of 5.50 and net profit margin of 5.67 provide insight into operational efficiency.
| Gross Margin | 22.69 |
| Operating Margin | 5.50 |
| Pretax Margin | 7.64 |
| Profit Margin | 5.67 |
| EBITDA Margin | 5.50 |
Dividends & Yields
The company's payout ratio of 26.56 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 1.22 |
| Dividend Yield | N/A |
| Payout Ratio | 26.56 |
| Shareholder Yield | 0.04 |
| FCF Yield | 0.16 |
Scores
iLex Medical Ltd. posts an Altman Z-Score of 137.46, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 137.46 |